X4 Pharmaceuticals
(NASDAQ) XFOR
X4 Pharmaceuticals Financials at a Glance
Market Cap
$385.50M
Revenue (TTM)
$35.11M
Net Income (TTM)
$79.20M
EPS (TTM)
$-4.34
P/E Ratio
-0.98
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$4.22
Volume
206,099
Open
$4.23
Price
$4.22
Volume
206,099
Open
$4.23
Previous Close
$4.24
Daily Range
$4.17 - $4.43
52-Week Range
$1.35 - $6.96
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$4.22
Volume
206,099
Open
$4.23
Previous Close
$4.24
Daily Range
$4.17 - $4.43
52-Week Range
$1.35 - $6.96
XFOR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout X4 Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
45
CEO
Paula S. Ragan, PhD
Website
www.x4pharma.comHeadquarters
Boston, MA 02134, US
XFOR Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-76%
Return on Capital
-33%
Return on Assets
-27%
Earnings Yield
-1.02%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$385.50M
Shares Outstanding
90.92M
Volume
206.10K
Short Interest
0.00%
Avg. Volume
478.48K
Financials (TTM)
Gross Profit
$28.86M
Operating Income
$86.88M
EBITDA
$85.61M
Operating Cash Flow
$85.62M
Capital Expenditure
$3.00M
Free Cash Flow
$88.62M
Cash & ST Invst.
$253.00M
Total Debt
$77.28M
X4 Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.57M
+79.1%
Gross Profit
$1.70M
+50.5%
Gross Margin
66.36%
N/A
Market Cap
$385.50M
N/A
Market Cap/Employee
$2.70M
N/A
Employees
143
N/A
Net Income
$23.93M
+39.9%
EBITDA
$38.12M
-3.1%
Quarterly Fundamentals
Net Cash
$175.71M
+632.9%
Accounts Receivable
$573.00K
-66.5%
Inventory
$4.48M
+59.0%
Long Term Debt
$76.29M
-0.7%
Short Term Debt
$994.00K
-20.5%
Return on Assets
-27.27%
N/A
Return on Invested Capital
-32.82%
N/A
Free Cash Flow
$15.53M
+53.0%
Operating Cash Flow
$15.53M
+52.9%